Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Policy
CAS, a division of the American Chemical Society, held its second annual Innovation Summit at the Zhangjiang Hi-Tech Park in Shanghai on Nov. 16. The meeting focused on drug discovery and development strategies for Chinese pharmaceutical and biotech firms. The speakers included Yang Ye, deputy director of the Shanghai Institute of Materia Medica, and Haijun Dong, chief executive officer of the custom chemistry firm PharmaBlock Science.
Attendees also heard from T.J. Deng, China managing director of the U.S. contract research firm BioDuro. Deng described the services that his firm could offer to Chinese clients.
This article has been sent to the following recipient: